Literature DB >> 15289770

Use of Rome II criteria in childhood defecation disorders: applicability in clinical and research practice.

Wieger P Voskuijl1, Jarom Heijmans, Hugo S A Heijmans, Jan A J M Taminiau, Marc A Benninga.   

Abstract

OBJECTIVES: To evaluate the prevalence of pediatric functional gastrointestinal disorders with the use of the Rome II criteria and to compare these data with the classic Iowa criteria. STUDY
DESIGN: Patients recorded defecation and encopresis frequency. A standard history was taken and a physical examination including a rectal examination was done. The prevalence of both criteria was assessed and compared.
RESULTS: One hundred ninety-eight consecutive patients (age, 0.66 to 15.76 years; 131 male subjects) were included. According to the Rome II criteria, 64%, 18%, and 21% of patients fulfilled the criteria for functional constipation, functional fecal retention, and functional nonretentive fecal soiling, respectively. Using the classic criteria, 74% and 18% of patients fulfilled the criteria for pediatric constipation and solitary encopresis, respectively; 16% of the patients fulfilling the pediatric constipation criteria were not recognized by the Rome II constipation criteria. Fair agreement was found between functional nonretentive fecal soiling and solitary encopresis. Encopresis was present in 79% of constipated children.
CONCLUSIONS: The Rome criteria are restrictive and exclude several children with constipation. We recommend including encopresis and rectal digital examination and excluding arbitrary age limits and retentive behavior in the revision of the Rome criteria.

Entities:  

Mesh:

Year:  2004        PMID: 15289770     DOI: 10.1016/j.jpeds.2004.04.050

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  13 in total

1.  Constipation in children: novel insight into epidemiology, pathophysiology and management.

Authors:  Shaman Rajindrajith; Niranga Manjuri Devanarayana
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

Review 2.  Constipation in children: fibre and probiotics.

Authors:  Merit M Tabbers; Marc A Benninga
Journal:  BMJ Clin Evid       Date:  2015-03-10

Review 3.  Clinical practice : diagnosis and treatment of functional constipation.

Authors:  Merit M Tabbers; Nicole Boluyt; Marjolein Y Berger; Marc A Benninga
Journal:  Eur J Pediatr       Date:  2011-06-24       Impact factor: 3.183

4.  Manometric assessment of idiopathic megarectum in constipated children.

Authors:  Giuseppe Chiarioni; Giuseppe de Roberto; Alessandro Mazzocchi; Antonio Morelli; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

5.  The Leech method for diagnosing constipation: intra- and interobserver variability and accuracy.

Authors:  Fleur de Lorijn; Rick R van Rijn; Jarom Heijmans; Johannes B Reitsma; Wieger P Voskuijl; Onno D F Henneman; Jan A Taminiau; Marc A Benninga
Journal:  Pediatr Radiol       Date:  2005-11-10

Review 6.  Constipation in children.

Authors:  Merit M Tabbers; Nicole Boluyt; Marjolein Y Berger; Marc A Benninga
Journal:  BMJ Clin Evid       Date:  2010-04-06

7.  Prevalence rates for constipation and faecal and urinary incontinence.

Authors:  Vera Loening-Baucke
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

Review 8.  Coexistence of constipation and incontinence in children and adults.

Authors:  S Nurko; S M Scott
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-02       Impact factor: 3.043

9.  The usefulness of ultrasound examination of the bowel as a method of assessment of functional chronic constipation in children.

Authors:  Artur Bijoś; Mieczysława Czerwionka-Szaflarska; Artur Mazur; Wrzeslaw Romañczuk
Journal:  Pediatr Radiol       Date:  2007-10-19

Review 10.  Epidemiology of functional gastrointestinal disorders in infants and toddlers: A systematic review.

Authors:  Ana Paula Ferreira-Maia; Alicia Matijasevich; Yuan-Pang Wang
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.